DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT
In the second quarter of FY2027, Dr. Reddy's Labs experienced a downturn in both revenue and profit. However, the company supports new trade margin regulations that aim to improve access to vital medicines. With a commitment to boosting...
Read more: https://economictimes.indiatimes.com/markets/stock...
Scan with your phone
Scan with your phone